Nkarta Inc. Insider Trading

NKTX

Last 12 months

Insiders sold 70K and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. The last open-market buy by an executive or director was in Mar 2024.

Net open-market

−70K

0 buys · 3 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 2

executives and directors

Last open-market buy

Mar 2024

Mar 27, 2024

Get an email when NKTX's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jun 18	Paul J Hastings Chief Executive Officer	SoldNo plan	1,776	$2.71	5K	0.5%	Form 4
Jan 15	Paul J Hastings Chief Executive Officer	SoldNo plan	26,046	$2.07	54K	6.3%	Form 4
Jan 15	Nadir Mahmood President	SoldNo plan	5,649	$2.07	12K	3.3%	Form 4
Jun 18, 2025	Paul J Hastings Chief Executive Officer	SoldNo plan	1,790	$1.79	3K	0.6%	Form 4
Jan 15, 2025	David Shook See Remarks	SoldNo plan	8,638	$2.20	19K	4.3%	Form 4
Jan 15, 2025	Alyssa Levin See Remarks	SoldNo plan	5,838	$2.20	13K	5.4%	Form 4
Jan 15, 2025	Ralph Brandenberger Chief Technical Officer	SoldNo plan	7,447	$2.20	16K	5.6%	Form 4
Jan 15, 2025	Paul J Hastings Chief Executive Officer	SoldNo plan	17,378	$2.20	38K	5.2%	Form 4
Jan 15, 2025	Alicia J. Hager Chief Legal Officer	SoldNo plan	9,584	$2.20	21K	6.1%	Form 4

Jun 18No plan
Paul J Hastings
Chief Executive Officer · sold 1,776 at $2.71
5K
0.5% of stake
Jan 15No plan
Paul J Hastings
Chief Executive Officer · sold 26,046 at $2.07
54K
6.3% of stake
Jan 15No plan
Nadir Mahmood
President · sold 5,649 at $2.07
12K
3.3% of stake
Jun 18, 2025No plan
Paul J Hastings
Chief Executive Officer · sold 1,790 at $1.79
3K
0.6% of stake
Jan 15, 2025No plan
David Shook
See Remarks · sold 8,638 at $2.20
19K
4.3% of stake
Jan 15, 2025No plan
Alyssa Levin
See Remarks · sold 5,838 at $2.20
13K
5.4% of stake
Jan 15, 2025No plan
Ralph Brandenberger
Chief Technical Officer · sold 7,447 at $2.20
16K
5.6% of stake
Jan 15, 2025No plan
Paul J Hastings
Chief Executive Officer · sold 17,378 at $2.20
38K
5.2% of stake
Jan 15, 2025No plan
Alicia J. Hager
Chief Legal Officer · sold 9,584 at $2.20
21K
6.1% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch NKTX, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with NKTX

CompareIntrinsic value

TNXPTonix Pharmaceuticals Holding Corp

$5.09-3.60%40

SCYXScynexis, Inc.

$3.72-3.63%40

HROWHarrow Inc.

$28.24-5.84%46

HRTXHeron Therapeutics Inc.

$0.28-3.45%36

RCKTRocket Pharmaceuticals Inc.

$2.44-3.94%10

BBIOBridgeBio Pharma, Inc.

$74.95+5.97%30

LGNDLigand Pharmaceuticals Inc.

$322.75+1.71%36

MRKMerck & Co., Inc.

$149.52+2.18%41

Held by ETFs

NKTX is in 2 US ETFs. The largest of them, with NKTX's weight in each:

Spot a number that looks wrong? Check it in NKTX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing NKTX

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.